Combination sucralfate and histamine2-antagonist therapy.
Gales
M A
MA
Department of Pharmacy Practice, School of Pharmacy, Southwestern Oklahoma State University, Oklahoma City.
Steadman
B K
BK
D004066:Digestive System Diseases / Q000188:drug therapy*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000188:drug therapy; D005260:Female; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D013276:Stomach Ulcer / Q000188:drug therapy; D013392:Sucralfate / Q000627:therapeutic use*
D006635:Histamine H2 Antagonists; D013392:Sucralfate